JP2014515921A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014515921A5 JP2014515921A5 JP2014509467A JP2014509467A JP2014515921A5 JP 2014515921 A5 JP2014515921 A5 JP 2014515921A5 JP 2014509467 A JP2014509467 A JP 2014509467A JP 2014509467 A JP2014509467 A JP 2014509467A JP 2014515921 A5 JP2014515921 A5 JP 2014515921A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- molecule
- sequence
- substitution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161483531P | 2011-05-06 | 2011-05-06 | |
| US61/483,531 | 2011-05-06 | ||
| PCT/US2012/036456 WO2012154530A1 (en) | 2011-05-06 | 2012-05-04 | Recombinant immunotoxin targeting mesothelin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017043879A Division JP2017140029A (ja) | 2011-05-06 | 2017-03-08 | メソテリンを標的とする組換え免疫毒素 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014515921A JP2014515921A (ja) | 2014-07-07 |
| JP2014515921A5 true JP2014515921A5 (https=) | 2015-06-25 |
| JP6169561B2 JP6169561B2 (ja) | 2017-07-26 |
Family
ID=46147033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509467A Active JP6169561B2 (ja) | 2011-05-06 | 2012-05-04 | メソテリンを標的とする組換え免疫毒素 |
| JP2017043879A Pending JP2017140029A (ja) | 2011-05-06 | 2017-03-08 | メソテリンを標的とする組換え免疫毒素 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017043879A Pending JP2017140029A (ja) | 2011-05-06 | 2017-03-08 | メソテリンを標的とする組換え免疫毒素 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10683362B2 (https=) |
| EP (1) | EP2704739B1 (https=) |
| JP (2) | JP6169561B2 (https=) |
| KR (1) | KR20140036216A (https=) |
| CN (1) | CN103648525B (https=) |
| AU (1) | AU2012253896B2 (https=) |
| BR (1) | BR112013028537A2 (https=) |
| CA (1) | CA2835070C (https=) |
| CL (1) | CL2013003182A1 (https=) |
| CO (1) | CO6862104A2 (https=) |
| CR (1) | CR20130571A (https=) |
| EC (1) | ECSP13013067A (https=) |
| ES (1) | ES2641877T3 (https=) |
| IL (1) | IL229198A0 (https=) |
| MA (1) | MA35244B1 (https=) |
| MX (1) | MX2013012905A (https=) |
| PE (1) | PE20141454A1 (https=) |
| PH (1) | PH12013502264A1 (https=) |
| RU (1) | RU2600067C2 (https=) |
| SG (1) | SG194787A1 (https=) |
| WO (1) | WO2012154530A1 (https=) |
| ZA (1) | ZA201308270B (https=) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2600067C2 (ru) | 2011-05-06 | 2016-10-20 | Дзе Гавермент Оф Дзе Юнайтед Стейтс Оф Америка Эз Репрезентед Бай Дзе Секретари Оф Дзе Депармент Оф Хелс Энд Хьюман Сёрвисез | Рекомбинантный иммунотоксин, нацеленный на мезотелин |
| US8932586B2 (en) | 2011-09-06 | 2015-01-13 | Intrexon Corporation | Modified forms of Pseudomonas exotoxin A |
| RS60280B1 (sr) | 2013-03-12 | 2020-06-30 | Molecular Templates Inc | Citotoksični proteini koji sadrže ciljane vezujuće regione za ćelije i regioni shiga toksina a podjedinice za selektivno ubijanje određenih vrsta ćelija |
| WO2014182532A1 (en) * | 2013-05-07 | 2014-11-13 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Mesothelin-specific immunocytokine and use thereof |
| JP6584012B2 (ja) | 2013-10-06 | 2019-10-02 | アメリカ合衆国 | 改変シュードモナス外毒素ａ |
| CN111909278B (zh) | 2014-01-27 | 2024-04-09 | 分子模板公司 | Mhc i类表位递送多肽 |
| US10421958B2 (en) | 2014-02-05 | 2019-09-24 | Molecular Templates, Inc. | Methods of screening, selecting, and identifying cytotoxic recombinant polypeptides based on an interim diminution of ribotoxicity |
| US11142584B2 (en) | 2014-03-11 | 2021-10-12 | Molecular Templates, Inc. | CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same |
| ES2919749T3 (es) | 2014-06-11 | 2022-07-28 | Molecular Templates Inc | Moléculas dirigidas a células citotóxicas resistentes a la escisión por proteasa |
| MX2017010072A (es) | 2015-02-05 | 2017-11-09 | Molecular Templates Inc | Moleculas multivalentes que se enlazan a cd20, las cuales comprenden regiones efectoras de la subunidad a de la toxina shiga, y composiciones enriquecidas de las mismas. |
| WO2016146833A1 (en) | 2015-03-19 | 2016-09-22 | F. Hoffmann-La Roche Ag | Biomarkers for nad(+)-diphthamide adp ribosyltransferase resistance |
| AU2016271124C1 (en) | 2015-05-30 | 2020-05-14 | Molecular Templates, Inc. | De-immunized, Shiga toxin a subunit scaffolds and cell-targeting molecules comprising the same |
| US20170096485A1 (en) * | 2015-10-02 | 2017-04-06 | Hoffmann-La Roche Inc. | Bispecific t cell activating antigen binding molecules |
| EP3356410B1 (en) * | 2015-10-02 | 2021-10-20 | F. Hoffmann-La Roche AG | Bispecific anti-ceaxcd3 t cell activating antigen binding molecules |
| EP3184547A1 (en) | 2015-10-29 | 2017-06-28 | F. Hoffmann-La Roche AG | Anti-tpbg antibodies and methods of use |
| EP4026848A1 (en) | 2015-12-09 | 2022-07-13 | F. Hoffmann-La Roche AG | Type ii anti-cd20 antibody for reducing the cytokine release syndrome |
| JP6949030B2 (ja) | 2016-01-08 | 2021-10-13 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Ｐｄ−１軸結合アンタゴニスト及び抗ｃｅａ／抗ｃｄ３二重特異性抗体を用いたｃｅａ陽性がんの治療方法 |
| WO2017196847A1 (en) | 2016-05-10 | 2017-11-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens |
| WO2017208018A1 (en) * | 2016-06-02 | 2017-12-07 | Immunocore Limited | Dosing regimen for gp100-specific tcr - anti-cd3 scfv fusion protein |
| WO2017211278A1 (en) * | 2016-06-06 | 2017-12-14 | Asclepiumm Taiwan Co., Ltd | Antibody fusion proteins for drug delivery |
| WO2017214182A1 (en) | 2016-06-07 | 2017-12-14 | The United States Of America. As Represented By The Secretary, Department Of Health & Human Services | Fully human antibody targeting pdi for cancer immunotherapy |
| EP3494135A1 (en) | 2016-08-02 | 2019-06-12 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Monoclonal antibodies targeting glypican-2 (gpc2) and use thereof |
| WO2018106895A1 (en) | 2016-12-07 | 2018-06-14 | Molecular Templates, Inc. | Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation |
| AU2017382883B2 (en) | 2016-12-21 | 2024-07-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibodies specific for FLT3 and uses thereof |
| EP3573648B1 (en) | 2017-01-25 | 2023-11-22 | Molecular Templates, Inc. | Cell-targeting molecules comprising de-immunized, shiga toxin a subunit effectors and cd8+ t-cell epitopes |
| CN108624607B (zh) * | 2017-03-16 | 2021-11-16 | 上海恒润达生生物科技股份有限公司 | 靶向mesothelin的嵌合抗原受体并对其双重修饰的方法和用途 |
| CN108624608B (zh) * | 2017-03-17 | 2021-11-16 | 上海恒润达生生物科技股份有限公司 | 靶向mesothelin的第四代嵌合抗原受体的制备方法和用途 |
| EP3600590B1 (en) | 2017-03-27 | 2025-10-01 | Cidra Corporate Services LLC | Removal of hydrophobic particles using carbon dioxide |
| CN108728458B (zh) * | 2017-04-21 | 2021-11-16 | 上海恒润达生生物科技股份有限公司 | 靶向mesothelin的嵌合抗原受体并联合表达IL-15的方法和用途 |
| WO2018213612A1 (en) | 2017-05-18 | 2018-11-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-mesothelin polypeptides and proteins |
| WO2018213064A1 (en) | 2017-05-19 | 2018-11-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human monoclonal antibody targeting tnfer2 for cancer immunotherapy |
| CN109134660B (zh) * | 2017-06-16 | 2022-07-01 | 上海恒润达生生物科技股份有限公司 | 靶向Mesothelin的嵌合抗原受体并联合表达抗PD1抗体的方法及其用途 |
| WO2019005208A1 (en) | 2017-06-30 | 2019-01-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | ANTIBODIES TO HUMAN MESOTHELIN AND USES IN ANTICANCER THERAPY |
| US11795235B2 (en) * | 2017-09-18 | 2023-10-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunotoxins with albumin binding domain |
| WO2019118760A1 (en) | 2017-12-13 | 2019-06-20 | Inovio Pharmaceuticals, Inc. | Cancer vaccines targeting mesothelin and uses thereof |
| AU2019257343A1 (en) | 2018-04-17 | 2020-09-10 | Molecular Templates, Inc. | HER2-targeting molecules comprising de-immunized, Shiga toxin A Subunit scaffolds |
| EP3820903A1 (en) | 2018-07-12 | 2021-05-19 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Affinity matured cd22-specific monoclonal antibody and uses thereof |
| CN112585163B (zh) | 2018-08-08 | 2025-03-25 | 美国政府(由卫生和人类服务部的部长所代表) | 靶向磷脂酰肌醇蛋白聚糖-2的高亲和力单克隆抗体及其用途 |
| US12180296B2 (en) | 2019-01-08 | 2024-12-31 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Cross species single domain antibodies targeting mesothelin for treating solid tumors |
| WO2020154150A1 (en) | 2019-01-22 | 2020-07-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | High affinity monoclonal antibodies targeting glypican-1 and methods of use |
| CN114729041B (zh) | 2019-10-22 | 2024-12-31 | 美国政府(由卫生和人类服务部的部长所代表) | 用于治疗多种实体瘤的靶向b7h3（cd276）的高亲和力纳米抗体 |
| CN112210008A (zh) * | 2020-07-16 | 2021-01-12 | 上海恒润达生生物科技有限公司 | 一种新型抗人msln抗体及其用途 |
| JP2023536627A (ja) | 2020-08-05 | 2023-08-28 | ドラゴンフライ セラピューティクス， インコーポレイテッド | Ｅｇｆｒを標的とする抗体およびその使用 |
| WO2022093745A1 (en) | 2020-10-26 | 2022-05-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Single domain antibodies targeting sars coronavirus spike protein and uses thereof |
| CN112574953A (zh) * | 2020-12-11 | 2021-03-30 | 南通大学 | 一种间皮素嵌合抗原受体外泌体、及其制备方法和应用 |
| US20240218055A1 (en) | 2021-04-29 | 2024-07-04 | The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Lassa virus-specific nanobodies and methods of their use |
| US20240270851A1 (en) | 2021-06-09 | 2024-08-15 | The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Cross species single domain antibodies targeting pd-l1 for treating solid tumors |
| CN116023501A (zh) * | 2021-10-25 | 2023-04-28 | 三生国健药业（上海）股份有限公司 | 一种抗her2的免疫毒素分子、及其制备方法与应用 |
| WO2023076881A1 (en) | 2021-10-26 | 2023-05-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein |
| WO2023107954A1 (en) | 2021-12-08 | 2023-06-15 | Dragonfly Therapeutics, Inc. | Antibodies targeting 5t4 and uses thereof |
| EP4448566A1 (en) | 2021-12-17 | 2024-10-23 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Anti-mesothelin polypeptides, proteins, and chimeric antigen receptors |
| US20250177527A1 (en) * | 2022-01-07 | 2025-06-05 | Oricell Therapeutics Co., Ltd. | Chimeric antigen receptor targeting cldn18.2 and msln and use thereof |
| WO2024050399A1 (en) | 2022-09-01 | 2024-03-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes |
| WO2024104584A1 (en) | 2022-11-17 | 2024-05-23 | University Of Cape Town | Deimmunized pseudomonas exotoxin a |
| WO2024238346A1 (en) | 2023-05-12 | 2024-11-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Single domain antibodies that specifically bind the s2 subunit of sars-cov-2 spike protein and compositions and uses thereof |
| AU2024295016A1 (en) | 2023-07-20 | 2026-02-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Fully human monoclonal antibodies and chimeric antigen receptors against cd276 for the treatment of solid tumors |
| WO2025171238A1 (en) | 2024-02-07 | 2025-08-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Monoclonal antibodies that bind the juxta-membrane region of mesothelin and uses thereof |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4957735A (en) | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| JPS63501765A (ja) | 1985-11-01 | 1988-07-21 | インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド | 抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途 |
| US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5004697A (en) | 1987-08-17 | 1991-04-02 | Univ. Of Ca | Cationized antibodies for delivery through the blood-brain barrier |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5055303A (en) | 1989-01-31 | 1991-10-08 | Kv Pharmaceutical Company | Solid controlled release bioadherent emulsions |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5271961A (en) | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
| US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US5268164A (en) | 1990-04-23 | 1993-12-07 | Alkermes, Inc. | Increasing blood-brain barrier permeability with permeabilizer peptides |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| US5254342A (en) | 1991-09-30 | 1993-10-19 | University Of Southern California | Compositions and methods for enhanced transepithelial and transendothelial transport or active agents |
| DE69232137T2 (de) | 1991-11-25 | 2002-05-29 | Enzon Inc | Multivalente antigen-bindende proteine |
| AU668384B2 (en) | 1992-03-12 | 1996-05-02 | Alkermes Controlled Therapeutics, Inc. | Controlled release ACTH containing microspheres |
| WO1993025690A1 (en) | 1992-06-18 | 1993-12-23 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Recombinant pseudomonas exotoxin with increased activity |
| US5534496A (en) | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
| US5747654A (en) | 1993-06-14 | 1998-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| US6180377B1 (en) | 1993-06-16 | 2001-01-30 | Celltech Therapeutics Limited | Humanized antibodies |
| US5514670A (en) | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
| US5888773A (en) | 1994-08-17 | 1999-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Method of producing single-chain Fv molecules |
| JPH11513669A (ja) * | 1995-10-13 | 1999-11-24 | アメリカ合衆国 | ジスルフィド安定化抗体フラグメントを含む免疫毒素 |
| DE69726404T2 (de) | 1996-01-05 | 2004-09-09 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Mesothelinantigen, verfahren und testsatz zur targetierung |
| NO961031D0 (no) * | 1996-03-13 | 1996-03-13 | Det Norske Radiumshospital Tum | Fremgangsmåte til å drepe uönskede målceller |
| JP2001522241A (ja) | 1997-04-10 | 2001-11-13 | ロイヤル ネザーランズ アカデミー オブ アーツ アンド サイエンシズ | 診断方法および試薬 |
| US6211338B1 (en) * | 1997-11-28 | 2001-04-03 | Schering Corporation | Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide |
| US6809184B1 (en) | 1997-12-01 | 2004-10-26 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antibodies, including FV molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| US6296843B1 (en) | 1998-04-03 | 2001-10-02 | The Penn State Research Foundation | Mutagenized IL 13-based chimeric molecules |
| DK1180123T3 (da) | 1999-05-27 | 2008-10-13 | Us Gov Health & Human Serv | Immunkonjugater, der har höj bindingsaffinitet |
| RU2295329C2 (ru) * | 2001-09-12 | 2007-03-20 | ВиРекс Медикал Корпорейшн | Перекрывающее кровоток твердофазное средство с покрытием из иммобилизованного связывающего средства |
| US7317091B2 (en) * | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
| US20040091503A1 (en) * | 2002-08-20 | 2004-05-13 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
| US20040223966A1 (en) * | 2002-10-25 | 2004-11-11 | Wolfman Neil M. | ActRIIB fusion polypeptides and uses therefor |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| EP1828399A2 (en) * | 2004-12-14 | 2007-09-05 | Enzon Pharmaceuticals, Inc. | Polymer-linked pseudomonas exotoxin immunotoxin |
| CA2593648A1 (en) * | 2005-01-10 | 2006-07-13 | Research Development Foundation | Targeted chimeric molecules for cancer therapy |
| CA2600505C (en) | 2005-03-10 | 2016-05-03 | Morphotek, Inc. | Anti-mesothelin antibodies |
| AU2006275865B2 (en) | 2005-07-29 | 2012-06-28 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH | Mutated Pseudomonas exotoxins with reduced antigenicity |
| EP1945674A2 (en) * | 2005-11-03 | 2008-07-23 | Genentech, Inc. | Therapeutic anti-her2 antibody fusion polypeptides |
| US7846895B2 (en) | 2006-09-06 | 2010-12-07 | The Regents Of The University Of California | Selectively targeted antimicrobial peptides and the use thereof |
| PL2197903T3 (pl) * | 2007-09-04 | 2015-03-31 | Us Gov Health & Human Services | Delecje w domenie ii egzotoksyny a psuedomonas zmniejszające toksyczność niespecyficzną |
| CA2773665C (en) * | 2009-09-11 | 2018-02-20 | Ira H. Pastan | Improved pseudomonas exotoxin a with reduced immunogenicity |
| RU2600067C2 (ru) | 2011-05-06 | 2016-10-20 | Дзе Гавермент Оф Дзе Юнайтед Стейтс Оф Америка Эз Репрезентед Бай Дзе Секретари Оф Дзе Депармент Оф Хелс Энд Хьюман Сёрвисез | Рекомбинантный иммунотоксин, нацеленный на мезотелин |
-
2012
- 2012-05-04 RU RU2013148919/10A patent/RU2600067C2/ru active
- 2012-05-04 MX MX2013012905A patent/MX2013012905A/es not_active Application Discontinuation
- 2012-05-04 US US14/115,131 patent/US10683362B2/en active Active
- 2012-05-04 SG SG2013081799A patent/SG194787A1/en unknown
- 2012-05-04 WO PCT/US2012/036456 patent/WO2012154530A1/en not_active Ceased
- 2012-05-04 PE PE2013002456A patent/PE20141454A1/es not_active Application Discontinuation
- 2012-05-04 BR BR112013028537A patent/BR112013028537A2/pt not_active IP Right Cessation
- 2012-05-04 KR KR1020137032247A patent/KR20140036216A/ko not_active Withdrawn
- 2012-05-04 EP EP12722586.0A patent/EP2704739B1/en active Active
- 2012-05-04 JP JP2014509467A patent/JP6169561B2/ja active Active
- 2012-05-04 AU AU2012253896A patent/AU2012253896B2/en active Active
- 2012-05-04 ES ES12722586.0T patent/ES2641877T3/es active Active
- 2012-05-04 CN CN201280033583.7A patent/CN103648525B/zh active Active
- 2012-05-04 CA CA2835070A patent/CA2835070C/en active Active
- 2012-05-04 PH PH1/2013/502264A patent/PH12013502264A1/en unknown
-
2013
- 2013-10-31 IL IL229198A patent/IL229198A0/en unknown
- 2013-11-05 CR CR20130571A patent/CR20130571A/es unknown
- 2013-11-05 ZA ZA2013/08270A patent/ZA201308270B/en unknown
- 2013-11-06 CL CL2013003182A patent/CL2013003182A1/es unknown
- 2013-11-21 CO CO13274153A patent/CO6862104A2/es unknown
- 2013-12-04 EC ECSP13013067 patent/ECSP13013067A/es unknown
- 2013-12-06 MA MA36534A patent/MA35244B1/fr unknown
-
2017
- 2017-03-08 JP JP2017043879A patent/JP2017140029A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014515921A5 (https=) | ||
| RU2013148919A (ru) | Рекомбинантный иммунотоксин, нацеленный на мезотелин | |
| US20250270314A1 (en) | Anti-cdh17 monoclonal and bispecific antibodies and uses thereof | |
| CN107922486B (zh) | 异源二聚体多特异性抗体形式 | |
| Fujii et al. | PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin | |
| ES2566602T3 (es) | Anticuerpos anti-ErbB3 | |
| HRP20231118T1 (hr) | Sintetizirani polipeptidi koji vežu transferinske receptore | |
| JP2011526480A5 (https=) | ||
| HRP20180226T1 (hr) | Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc | |
| IL295534A (en) | Improved immunoglobulin variable domains | |
| FI3348571T3 (fi) | Yksidomeeninen vasta-aine ohjelmoitu solukuolema -ligandille (pd-l1) ja siitä peräisin oleva proteiini | |
| JP2019507762A5 (https=) | ||
| AU2018256487A1 (en) | Antibodies that bind to TL1A and their uses | |
| JP2018531000A5 (https=) | ||
| JP2017114866A5 (https=) | ||
| JP2013504328A5 (https=) | ||
| JP2016507523A5 (https=) | ||
| RU2022101604A (ru) | Улучшенные отдельные вариабельные домены иммуноглобулина, связывающиеся с сывороточным альбумином | |
| FI3683235T3 (fi) | Anti-IL-33-vasta-aineita ja niiden käyttöjä | |
| CA2926215A1 (en) | Modified pseudomonas exotoxin a | |
| RU2013124808A (ru) | Новое антитело против dr5 | |
| JP2016026215A5 (https=) | ||
| JP2017509323A5 (https=) | ||
| JP2014511680A5 (https=) | ||
| WO2011108008A3 (en) | Antibody for targeted induction of apoptosis, cdc and adcc mediated killing of cancer cells, tbl-cln1 |